Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole

1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole

1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole structure

1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole 

structure
  • CAS No:

    50257-40-4

  • Formula:

    C18H26N2O2S

  • Chemical Name:

    1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole

  • Synonyms:

    1H-Imidazole,1-[[2,4,6-tris(1-methylethyl)phenyl]sulfonyl]-;1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole;1-(2,4,6-Triisoprolylphenylsulfonyl)-1H-imidazole;1-(2,4,6-Triisopropylphenylsulfonyl)-1H-imidazole;1-(2,4,6-Triisopropylphenylsulfonyl)imidazole;1-(2,4,6-Triisopropyl-benzenesulfonyl)-1H-imidazole;1-[2,4,6-Tri(propan-2-yl)phenyl]sulfonylimidazole

  • Categories:

    Biochemical Engineering  >  Nucleoside Drugs

1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole Basic Attributes

334.48

334.48

256-509-5

DTXSID80198252

2933290090

Characteristics

60.3

4.6

1.1±0.1 g/cm3

118-119 °C

449.7°C at 760 mmHg

225.8±31.5 °C

1.563

Store at RT.

Safety Information

3

R36/37/38

23-24/25

P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

1-[[2,4,6-Tris(1-methylethyl)phenyl]sulfonyl]-1H-imidazole Use and Manufacturing

Methods of Manufacturing

To a stirred suspension of NaH (60percent in oil dispersion) (2.9 g, 72 mmol) in dry THF (200 mL) at 0C was added in portions 16 (2.5 g, 15.8 mmol), followed by 2, 4, 6-triisopropyl-benzenesulfonylimidazole (13 g, 39.6 mmol), and the whole mixture was then stirred for 3 h. Cold H2O (80 mL) was added, and the resulting mixture was extracted with EtOAc (3 × 50 mL). The combined extracts were washed with brine (50 mL) and then dried (anhydrous Na2SO4). Evaporation of the solvent gave the crude product, which was purified by flash chromatography on silica gel (hexane/EtOAc, 50:1) to afford 17 (2.5 g, 42percent yield) as colorless oil. [alpha]D20 -2.0 (c = 1.00, CH2Cl2); 96percent ee; 1H NMR (300 MHz, CDCl3): delta 1.04 (t, J = 7.5 Hz, 3 H), 1.22-1.28 (m, 18 H), 2.02-2.07 (m, 2 H), 2.62-2.68 (m, 2 H), 2.81 (dd, J = 2.5, 4.8 Hz, 1 H), 2.90-2.93 (m, 2 H), 3.22-3.25 (m, 1 H), 4.12-4.16 (m, 2 H), 4.50-4.55 (m, 1 H), 7.18 (s, 2 H); 13C NMR (75 MHz, CDCl3): delta 12.4, 13.9, 22.9, 23.6, 24.7, 24.8, 29.8, 34.3, 45.5, 52.5, 72.9, 79.4, 85.2, 123.8, 130.7, 150.6, 153.7; HRMS (ESI): m/z [M+Na]+ calcd for C23H34O4SNa: 429.2070; found: 429.2073.To a stirred suspension of NaH (60percent in oil dispersion) (2.9 g, 72 mmol) in dry THF (240 mL) at 0C was added in portions 7 (3.8 g, 24 mmol), followed by 2, 4, 6-triisopropyl-benzenesulfonylimidazole (20 g, 60 mmol), and the whole mixture was then stirred for 3 h. Cold H2O (100 mL) was added, and the resulting mixture was extracted with EtOAc (3 × 40 mL). The combined extracts were washed with brine (50 mL) and then dried (anhydrous Na2SO4). Evaporation of the solvent gave the crude product, which contains 12 and its regioisomer 13 with a ratio of 3:1. The mixture was purified by flash chromatography on silica gel (hexane/EtOAc, 50:1) to afford 12 and 13. For 12 (4.1g, 41percent yield; colorless oil): [alpha]D20 +2.0 (c = 1.00, CH2Cl2); 94.6percent ee; 1H NMR (300 MHz, CDCl3): delta 1.04 (t, J = 7.5 Hz, 3 H), 1.22-1.29 (m, 18 H), 2.01-2.08 (m, 2 H), 2.60-2.70 (m, 2 H), 2.81 (dd, J = 2.55, 4.81 Hz, 1 H), 2.90-2.93 (m, 2 H), 3.20-3.28 (m, 1 H), 4.12-4.16 (m, 2 H), 4.50-4.54 (m, 1 H), 7.18 (s, 2 H); 13C NMR (75 MHz, CDCl3): delta 12.3, 14.0, 23.0, 23.6, 24.7, 24.8, 29.8, 34.3, 45.5, 52.4, 72.8, 79.4, 85.2, 123.8, 130.7, 150.6, 153.7; HRMS (ESI): m/z [M+Na]+ calcd for C23H34O4SNa: 429.2070; found: 429.2073. For 13 (1.3g, 14percent yield; colorless oil): 1H NMR (400 MHz, CDCl3): delta 1.08 (t, J =7.5 Hz, 3H), 1.25-1.28 (m, 18H), 2.07-2.26 (m, 3H), 2.52-2.61 (m, 1H), 2.85-2.99 (m, 1H), 3.18-3.28 (m, 2H), 4.03-4.22 (m, 3H), 4.39 (dd, J = 3.81, 11.42 Hz, 1H), 7.20 (s, 2H); 13C NMR (100 MHz, CDCl3): delta 12.4, 14.0, 19.1, 23.7, 24.8, 24.8, 29.8, 34.4, 53.5, 54.7, 67.1, 73.1, 84.9, 124.0, 129.1, 151.0, 154.1; HRMS (ESI): m/z [M+Na]+ calcd for C23H34O4SNa: 429.2070; found: 429.2073. The enantiomeric excess of 12 was determined by chiral HPLC analysis (column, Chiralpak AD-H, 4.6 mm × 250mm, n-hexane / i-PrOH = 97:3; flow rate: 0.5 mL/min, lambda = 230nm). The retention times corresponding to 12 and its enantiomer are 12.8 min and 10.2 min, respectively.

Uses

Coupling or condensation reagents used in oligonucleotide synthesis.

Computed Properties

Molecular Weight:334.5
XLogP3:4.6
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:5
Exact Mass:334.17149925
Monoisotopic Mass:334.17149925
Topological Polar Surface Area:60.3
Heavy Atom Count:23
Complexity:464
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.